The digestive health market could reach $71.95 billion by 2027 with the rising awareness of gut health issues, says Fortune Business Insights. That could be incredibly beneficial for companies such as Psyched Wellness Ltd. (CSE:PSYC)(OTC:PSYCF), Sprouts Farmers Market Inc. (NASDAQ:SFM), General Mills Inc. (NYSE:GIS), Nestle (OTC:NSRGY), and Danone (OTC:DANOY).
“Gut health goes far beyond solely digestive health, encompassing immunity support and weight management. Gut health refers to a well-balanced microbiota in the gastrointestinal tract and is shown to impact physical and mental wellbeing. Gut health is also related to numerous diseases, such as diabetes, obesity or autoimmune disease, and recent research even suggests an impact on mood due to the so-called gut-brain axis,” as reported by Euromonitor International. In addition according to Grand View Research, the market could be worth about $57.5 billion by 2025. “Rising inclination of consumers toward digestive food products due to their health benefits is also expected to boost the market growth,” they noted.
Psyched Wellness Just Initiated Next Pre-Clinical Trial Study on AME-1
Psyched Wellness Ltd.(CSE:PSYC)(OTC:PSYCF), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that the company and its CRO partner, KGK Science, has commenced the next preclinical trial study with AME-1.
This new study is a 14-day oral toxicity study of AME-1. It will provide the level of dose(s) that will be selected and administered for a subsequent long term 90-day oral toxicity study. The importance of this study is to determine dose-dependent effects along with determining the highest dose that is safe to use for a longer-term study. This is another key milestone in the further understanding of the effects of Psyched Welness’ AME-1 extract under a scientific methodology in pursuit of a safe dose for human consumption.
“This represents another milestone event in the scientific study of AME-1. The results of this study will further increase the knowledge and further identify the physical and chemical properties of AME-1,” says Brian Tancowny, scientific advisor for Psyched Wellness.
"The pre-clinical trial we are currently conducting is part of a number of smaller studies that need to happen in a specific order and, when completed, will combine to provide the foundation off of which our future products will be developed,” says Jeff Stevens, CEO. “As we embark on a new study or complete a study, we add significant value to the Company as we are pioneering a path to market for AME-1 derived health and wellness products.”
Other related developments from around the markets include:
Sprouts Farmers Market Inc. reported results for the 14-week fourth quarter and 53-week year ended January 3, 2021. Period-over-period increases stated herein reflect the comparison of 14 and 53 weeks in fourth quarter and fiscal year 2020 to 13 and 52 weeks in fourth quarter and fiscal year 2019, respectively. “In 2020, we generated record earnings and cash flow from a 15% increase in sales while absorbing costs associated with a 340% increase in ecommerce sales, paying record bonuses to our frontline team members, and opening 22 new stores,” said Jack Sinclair, chief executive officer of Sprouts Farmers Market. “Executing our strategic initiatives at a more rapid pace than we originally planned is fueling these encouraging results and establishing a solid base from which we can invest and grow. I want to thank not only our dedicated team members at Sprouts, but also our supply chain partners, vendors, farmers and growers, who worked collectively to make healthy food accessible to our customers in this extraordinary year.”
General Mills Inc. reported results for the third quarter ended February 28, 2021. “We continued to execute well and delivered profitable growth in the third quarter,” said General Mills Chairman and Chief Executive Officer Jeff Harmening. “We’ve made good progress on our fiscal 2021 priorities, including competing effectively, fueling investment in our brands and capabilities, and reducing our leverage. With our balance sheet in a strong position, we have resumed share repurchase activity in the fourth quarter. We’re continuing to advance our Accelerate strategy, including yesterday’s announcement of our proposed divestiture of our European Yoplait business. Looking ahead, we remain focused on strengthening our momentum and emerging from the pandemic a stronger company, even better positioned to drive long-term shareholder value.”
Nestle shareholders approved all of the Board of Directors' proposals at the 154th Annual General Meeting (AGM) that took place in Vevey today. This included the election of Lindiwe Majele Sibanda to the Board of Directors. Due to concerns for the health and safety of shareholders and in line with the current rules of the Swiss authorities, shareholders could not attend the meeting in person. All legal proceedings were carried out as required. Shareholders were able to exercise their voting rights through the Independent Representative, who acted on behalf of 58.2 percent of Nestlé's capital and 79.9 percent of Nestlé shares entitled to vote.
Danone’s Board announced key governance changes. First, the Board has decided that Emmanuel Faber will step down as Chairman and CEO. As a consequence, it has appointed Gilles Schnepp as Chairman of the Board with immediate effect. Second, the Board has decided to appoint Ve´ronique Penchienati-Bosetta, currently Chief Executive Officer International, and Shane Grant, currently Chief Executive Officer North America, to jointly lead the business while the search for a new CEO is underway. Ve´ronique Penchienati-Bosetta (CEO) and Shane Grant (deputy CEO) will work together, with a focused attention on operational execution.
Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for Psyched Wellness Ltd. by a third party. We own ZERO shares of Psyched Wellness Ltd. Please click here for full disclaimer.